Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00194857
Status:
TERMINATED
Last Update Posted:
2012-12-17
First Post:
2005-09-12
Brief Title:
Treatment of Anemia and Neutropenia in HIVHCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin
Sponsor:
Weill Medical College of Cornell University
Organization:
Weill Medical College of Cornell University
Study Overview
Official Title:
A Randomized Clinical Trial Comparing Two Management Strategies for Treatment of Neutropenia and Anemia Associated With Pegylated Interferon Plus Ribavirin Treatment of Compensated Chronic Hepatitis C in Adult Subjects Infected With HIV
Status:
TERMINATED
Status Verified Date:
2012-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to test two separate strategies for treatment of anemia low hemoglobin and neutropenia low white blood cells in HIVHCV coinfected patients who are being treated with pegylated interferon and ribavirin
Detailed Description:
This is a multi-center randomized open-labeled trial in subjects co-infected with hepatitis C HCV and human immunodeficiency virus type 1 HIV-1 who are naïve to anti-HCV therapy Subjects will receive PEG interferon alfa-2b PEG-IFN 15 mcgkgweek administered once weekly plus ribavirin RBV 13 2 mgkgday The goal of this study is to evaluate two different treatment options for anemia and neutropenia associated with the initiation of pegylated interferon and ribavirin This will result in completion of therapy and possibly a better viral sustained response
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 0801-858 | None | None | None |